| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Chlorhexidine gluconate 0.02% irrigation solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Product containing precisely chlorhexidine gluconate 10 milligram/1 gram conventional release dental gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 0.2% mouthwash |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Product containing precisely chlorhexidine gluconate 2 milligram/1 milliliter conventional release oromucosal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 0.2% mint mouthwash |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 5% concentrated solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Product containing precisely chlorhexidine gluconate 40 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 1 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 500 microgram/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 0.05% topical liquid sachet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 0.5% in 70% IMS hand rub |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 0.5% in 70% IMS spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 0.02% in 70% IMS spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 0.5% in 70% IMS solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 0.5% in 70% IMS surgical scrub |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 0.12% rinse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 1.2% |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 0.6386% rinse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 2.5mg oropharyngeal chip |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Product containing precisely chlorhexidine hydrochloride 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate+amethocaine hydrochloride 0.05%/0.015% throat spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Cetrimide 150 mg/mL and chlorhexidine gluconate 15 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Cetrimide 22.5 mg/mL and chlorhexidine gluconate 2.25 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate pink 0.05% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Product containing precisely cetrimide 5 milligram/1 milliliter and chlorhexidine gluconate (as chlorhexidine) 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Cetrimide 1.5 mg/mL and chlorhexidine gluconate 150 microgram/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate+cetrimide 1.5%/15% topical liquid sachet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate+cetrimide 0.015%/0.15% topical liquid sachet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine hydrochloride+neomycin sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate solution 1.25% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate pink 0.5% in 70% IMS spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate blue 0.5% in 70% IMS solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate pink 0.5% in 70% IMS solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate+sodium nitrite 0.5/0.1% in 70% IMS solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Product containing chlorhexidine gluconate and industrial methylated spirit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate+lidocaine hydrochloride 0.2%/0.05% throat spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate+lidocaine hydrochloride 0.2%/0.05% throat spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate+ethyl alcohol 1%/61% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 2%/isopropyl alcohol 70% topical sponge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Product containing precisely chlorhexidine gluconate 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 3.15%/isopropyl alcohol 70% topical swab |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate+lidocaine hydrochloride 0.2%/0.05% conventional release oromucosal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Chlorhexidine digluconate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
|
| Product containing precisely chlorhexidine gluconate 10 milligram/1 gram conventional release dental gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlorhexidine gluconate 10 milligram/1 gram conventional release dental gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlorhexidine gluconate 2 milligram/1 milliliter conventional release oromucosal spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlorhexidine gluconate 2 milligram/1 milliliter conventional release oromucosal spray (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Cetrimide 150 mg/mL and chlorhexidine gluconate 15 mg/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
2 |
| Cetrimide 150 mg/mL and chlorhexidine gluconate 15 mg/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Chlorhexidine gluconate 50 mg/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Chlorhexidine gluconate 50 mg/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlorhexidine gluconate 40 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlorhexidine gluconate 40 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Chlorhexidine gluconate 500 microgram/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Chlorhexidine gluconate 500 microgram/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlorhexidine gluconate 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlorhexidine gluconate 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Chlorhexidine gluconate 10 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Chlorhexidine gluconate 10 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlorhexidine gluconate 2 milligram/1 milliliter conventional release oromucosal solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlorhexidine gluconate 2 milligram/1 milliliter conventional release oromucosal solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Chlorhexidine gluconate 1 mg/mL and chlorobutanol 5 mg/mL oromucosal solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Chlorhexidine gluconate 1 mg/mL and chlorobutanol 5 mg/mL oromucosal solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Chlorhexidine gluconate 1 mg/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Chlorhexidine gluconate 1 mg/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Chlorhexidine gluconate 200 microgram/mL cutaneous spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Chlorhexidine gluconate 200 microgram/mL cutaneous spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter and sodium nitrite 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter and sodium nitrite 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oral spray (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oral spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely cetrimide 5 milligram/1 milliliter and chlorhexidine gluconate (as chlorhexidine) 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Cetrimide 1.5 mg/mL and chlorhexidine gluconate 150 microgram/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Cetrimide 1.5 mg/mL and chlorhexidine gluconate 150 microgram/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Cetrimide 22.5 mg/mL and chlorhexidine gluconate 2.25 mg/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Cetrimide 22.5 mg/mL and chlorhexidine gluconate 2.25 mg/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Cetrimide 5 mg/mL and chlorhexidine gluconate 500 microgram/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Cetrimide 5 mg/mL and chlorhexidine gluconate 500 microgram/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Cetrimide 150 mg/mL and chlorhexidine gluconate 15 mg/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Cetrimide 150 mg/mL and chlorhexidine gluconate 15 mg/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlorhexidine gluconate 2.5 milligram/1 gram and metronidazole 10 milligram/1 gram conventional release dental gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlorhexidine gluconate 2.5 milligram/1 gram and metronidazole 10 milligram/1 gram conventional release dental gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlorhexidine (as chlorhexidine gluconate) 40 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oromucosal spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oromucosal spray (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Chlorhexidine gluconate 2.5 mg/g and phenol 12 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
2 |
| Chlorhexidine gluconate 2.5 mg/g and phenol 12 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
2 |
| Chlorhexidine gluconate 2 mg/mL and lidocaine hydrochloride 500 microgram/mL oromucosal spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
| Chlorhexidine gluconate 2 mg/mL and lidocaine hydrochloride 500 microgram/mL oromucosal spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Chlorhexidine gluconate (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]